Essure removal for device-attributed symptoms: Quality of life evaluation before and after surgical removal - Archive ouverte HAL
Article Dans Une Revue Journal of Gynecology Obstetrics and Human Reproduction Année : 2021

Essure removal for device-attributed symptoms: Quality of life evaluation before and after surgical removal

Résumé

Introduction: Increasing reports of adverse effects have raised concerns about the Essure hysteroscopic sterilization method. Women suffering alleged complications of the Essure device often seek surgical removal. This study evaluated the quality of life (QoL) and postoperative outcomes in women undergoing Essure removal.Material and methods: This observational case series included 95 women. Removal was performed by laparoscopic salpingectomy-cornuectomy, or hysterectomy with bilateral salpingectomy. QoL was assessed preoperatively and three months postoperatively by SF-36 questionnaires [correlated physical health score (PCS) and mental health scores (MCS)]. Symptoms evolution was collected at three months, and complications at one month.Results: Sixty-four laparoscopic salpingectomy-cornuectomies, 33 laparoscopic hysterectomies, and eight vaginal hysterectomies were performed. Four intraoperative complications occurred (one conversion from cornuectomy to laparoscopic hysterectomy, one skin burn, two bladder injuries). Seven postoperative complications occurred (Clavien Dindo, grade 1 or 2). All components of the preoperative QoL scores were lower than those of the general population. PCS scores were lower preoperatively than postoperatively [37.6 versus 50.7; p<0.001]. MCS scores were lower preoperatively than postoperatively [29 versus 52.4; p<0.001]. 71% of patients showed an improvement of at least 10% in both PCS and MCS scores. Systemic and gynecologic symptoms were more frequent before than after surgery (98% versus 50%; p<0.001 and 77% versus 20%; p<0.001 respectively).Conclusions: Patients seeking Essure removal had an impaired preoperative QoL. They experienced a significant QoL improvement at three months post-operation. These findings will help clinicians to inform patients about their expected postoperative functional status and QoL.
Fichier principal
Vignette du fichier
S246878472030115X.pdf (202.22 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03651213 , version 1 (03-02-2023)

Licence

Identifiants

Citer

Sarah Francini, Martha Duraes, Axelle Charavil, Federico Manna, Claire Duflos, et al.. Essure removal for device-attributed symptoms: Quality of life evaluation before and after surgical removal. Journal of Gynecology Obstetrics and Human Reproduction, 2021, 50 (2), pp.101772. ⟨10.1016/j.jogoh.2020.101772⟩. ⟨hal-03651213⟩
14 Consultations
42 Téléchargements

Altmetric

Partager

More